Artelo biosciences to participate in the 2022 virtual growth conference presented by maxim group llc and hosted by m-vest on march 28th – 30th

Solana beach, calif., march 22, 2022 (globe newswire) -- artelo biosciences, inc. (nasdaq: artl), a clinical stage pharmaceutical company developing therapeutics that modulate lipid-signaling pathways, including the endocannabinoid system, today announced it has been invited to present at the 2022 virtual growth conference, presented by maxim group llc and hosted by m-vest, on march 28th - 30th from 9:00 a.m. - 5:00 p.m. edt.
ARTL Ratings Summary
ARTL Quant Ranking